189 related articles for article (PubMed ID: 8035402)
1. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases.
Brun JG; Jonsson R; Haga HJ
J Rheumatol; 1994 Apr; 21(4):733-8. PubMed ID: 8035402
[TBL] [Abstract][Full Text] [Related]
2. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity.
Brun JG; Haga HJ; Bøe E; Kallay I; Lekven C; Berntzen HB; Fagerhol MK
J Rheumatol; 1992 Jun; 19(6):859-62. PubMed ID: 1404121
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis.
Berntzen HB; Munthe E; Fagerhol MK
J Rheumatol; 1989 Nov; 16(11):1416-20. PubMed ID: 2600939
[TBL] [Abstract][Full Text] [Related]
5. Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis.
Homann C; Garred P; Graudal N; Hasselqvist P; Christiansen M; Fagerhol MK; Thomsen AC
Hepatology; 1995 Apr; 21(4):979-85. PubMed ID: 7705809
[TBL] [Abstract][Full Text] [Related]
6. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
8. The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis.
Berntzen HB; Fagerhol MK; Ostensen M; Mowinckel P; Høyeraal HM
J Rheumatol; 1991 Jan; 18(1):133-8. PubMed ID: 2023183
[TBL] [Abstract][Full Text] [Related]
9. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
Ellingsen T; Buus A; Stengaard-Pedersen K
J Rheumatol; 2001 Jan; 28(1):41-6. PubMed ID: 11196541
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A in the assessment of early inflammatory arthritis.
Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
[TBL] [Abstract][Full Text] [Related]
11. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
[TBL] [Abstract][Full Text] [Related]
13. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
Emlen W; Niebur J; Flanders G; Rutledge J
J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis.
Hammer HB; Kvien TK; Glennås A; Melby K
Clin Exp Rheumatol; 1995; 13(1):59-64. PubMed ID: 7774104
[TBL] [Abstract][Full Text] [Related]
16. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.
Hammer HB; Odegard S; Fagerhol MK; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
Ann Rheum Dis; 2007 Aug; 66(8):1093-7. PubMed ID: 17234650
[TBL] [Abstract][Full Text] [Related]
17. Soluble adhesion molecules in pediatric rheumatic diseases.
Bloom BJ; Miller LC; Blier PR
J Rheumatol; 2002 Apr; 29(4):832-6. PubMed ID: 11950029
[TBL] [Abstract][Full Text] [Related]
18. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
19. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
